Trial intelligence / Profile preview

Haloperidol prophylaxis for delirium prevention in older emergency department admissions

NL-OMON21334Not yet recruiting

Sponsor
Amsterdam UMC
Start
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in delirium comparing Haloperidol prophylaxis with Placebo (2 arms). Primary endpoints: In-hospital delirium incidence and In-hospital delirium duration. Planned start Nov 2012; status: not yet recruiting.

02

Drugs

haloperidol
03

Conditions

delirium

Beyond the preview

Go deeper on NL-OMON21334.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON21334.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call